EBiSC

EBiSC

Details

DC Role: 
Project Partner
Duration: 
1 Jan 2014 - 31 Dec 2017
Client: 
Innovative Medicines Initiative, European Commission (IMI)

ABOUT THIS PROJECT

The goal of European Bank for induced Stem Cells (EBiSC) coordinated by Pfizer Ltd. and managed by Roslin Cells Sciences Ltd. is to establish the supply chain for research-grade human induced pluripotent stem cells (iPSC) with a non-for-profit Biobank in its core.

The Biobank will provide the distribution of disease-relevant quality-controlled iPSC lines, data and services to any qualified user.

Our responsibility is to develop the EBiSC information management system (IMS) and support the business requirement of EBiSC users.

Latest Tweets

Douglas Connect (1 week ago)
Towards Semantic Interoperability of Publicly Available Data https://t.co/YIv7avHvns
Douglas Connect (4 weeks ago)
A couple of places are still available for the eChemInfo workshop in Milano starting July 17. Register now at https://t.co/NxBAmGIFtz.
Douglas Connect (4 weeks ago)
RT @barryhardy: Your OpenTox newsletter is here! https://t.co/YVaUuCIe2G https://t.co/41xKSQSVQn
Douglas Connect (5 weeks ago)
Find out details on the new e-Infrastructure supporting #knowledgesharing in risk assessment at https://t.co/WTnwSNUnRU #OpenRiskNet #H2020
Douglas Connect (6 weeks ago)
Integrated testing strategy (ITS) for Skin Sensitisation. Skin Sens ITS predictor https://t.co/OK2cryVLmb More info https://t.co/94plUrof3G

Get in touch

  • Address: Douglas Connect GmbH
    Technology Park Basel
    Hochbergerstrasse 60C
    CH-4057 Basel / Basel-Stadt
    Switzerland
  • Phone: +41 61 851 0170
  • Email: info@douglasconnect.com